Reuters: Regulatory News: BRIEF-Astrazeneca enters agreement with Hanmi, Amneal in US Nexium patent case

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

BRIEF-Astrazeneca enters agreement with Hanmi, Amneal in US Nexium patent case Jun 3rd 2013, 08:24 LONDON, June 3 | Mon Jun 3, 2013 4:24am EDT LONDON, June 3 (Reuters) - * Astrazeneca enters agreement with hanmi pharmaceutical and amnealpharmaceuticals in US nexium patent litigation * Astrazeneca- amneal and hanmi have conceded the validity, enforceability of

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions